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Abstract
With recent advances in understanding of the neuroscience of risk taking, attention is now turning to genetic factors that
may contribute to individual heterogeneity in risk attitudes. In this paper we test for genetic associations with risk attitude
measures derived from both the psychology and economics literature. To develop a long-term prospective study, we first
evaluate both types of risk attitudes and find that the economic and psychological measures are poorly correlated,
suggesting that different genetic factors may underlie human response to risk faced in different behavioral domains. We
then examine polymorphisms in a spectrum of candidate genes that affect neurotransmitter systems influencing dopamine
regulation or are thought to be associated with risk attitudes or impulsive disorders. Analysis of the genotyping data
identified two single nucleotide polymorphisms (SNPs) in the gene encoding the alpha 4 nicotine receptor (CHRNA4,
rs4603829 and rs4522666) that are significantly associated with harm avoidance, a risk attitude measurement drawn from
the psychology literature. Novelty seeking, another risk attitude measure from the psychology literature, is associated with
several COMT (catechol-O-methyl transferase) SNPs while economic risk attitude measures are associated with several
VMAT2 (vesicular monoamine transporter) SNPs, but the significance of these associations did not withstand statistical
adjustment for multiple testing and requires larger cohorts. These exploratory results provide a starting point for
understanding the genetic basis of risk attitudes by considering the range of methods available for measuring risk attitudes
and by searching beyond the traditional direct focus on dopamine and serotonin receptor and transporter genes.
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Introduction
Risk attitudes have been correlated to a broad array of financial,
employment, health, safety and social decisions made by humans,
including financial investments, insurance coverage, smoking,
drinking, sport participation, migration and self-employment
status [1],[2],[3]. Risk attitudes have also been hypothesized as
susceptibility factors for pathological gambling [4,5,6], anxiety and
mood disorders [7,8,9] and as a susceptibility factor for impulse
control disorders (ICD) among Parkinson’s patients on dopamine
therapies [10]. Risk attitudes have also been correlated to
neurological responses during imaging studies featuring decision
making tasks [11,12] and to the volume of key brain regions
[13,14].
Given the emerging interest in risk attitude measures at the
nexus of economics, psychology and neurology, attention is now
turning to possible genetic factors that contribute to individual
heterogeneity in risk attitudes. Such an interest is buttressed by
twin studies that have estimated the heritability of risk attitudes
near 20% among a Swedish sample [15] and near 60% among a
Chinese sample [16], and by twin studies that estimate the
heritability of pathological gambling, which has been estimated
near 60% in a U.S. sample [17]. Several studies have attempted to
associate risk attitudes with particular genotypes. However these
studies differ in terms of how risk attitude is defined and measured
and in terms of types of genetic variation investigated.
The risk attitude measures used in genetics studies emerge from two
different bodies of literature. Risk attitudes such as harm avoidance
(HA) and novelty seeking (NS) are the most commonly explored risk
attitudes in behavioral genetics studies. These measures originate in the
psychology literature (Temperament and Character Inventory, [18])
and are used broadly by behavioral neuroscientists and geneticists.
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goodness of fit between various statements concerning a wide range of
behaviors (e.g., ‘‘I jump into things without thinking…’’) and his or her
own personality and behavior. NS and HA were originally
hypothesized to be driven by variation in the dopamine and serotonin
systems, respectively [19]. Several studies have shown associations in
NS and HA with polymorphisms thought to affect dopamine and
serotonin receptors and transporters, including DRD2, DRD4, DRD5
and DAT [20,21,22] and SERT [23,24]. NS or HA also have been
associated with polymorphisms thought to impact dopamine and
serotonin synthesis or metabolism, e.g., catechol-O-methyl transferase
(COMT, [25]) and tryptophan hydroxylase-2 gene (TPH2 [26]). Other
research has pointed to genetic associations beyond dopamine and
serotonin, such as brain-derived neurotrophic factor (BDNF, [27]).
The second type of risk attitude measurement comes from the
economics literature. Economists commonly measure risk attitudes
by recording subjects’ decisions among competing financial
gambles or investment opportunities. Economic risk attitudes
often show a limited correlation to psychologically based
measurements of risk attitude [28], suggesting that risk attitudes
may be domain specific [29] and not captured precisely by more
general risk attitude measures such as HA and NS. Risk attitudes
derived from financial choice tasks have also been associated with
genetic variation, though less work has focused on this class of risk
attitude measurements. For example, Roussos et al. [30] associated
risk tendencies measured during the Iowa Gambling Task with a
COMT polymorphism; Kuhnen and Chiao [31] associated risky
investment behavior observed during an investment game with
polymorphisms in SERT and DRD4; and Dreber et al. [32]
associated financial risk taking with a DRD4 polymorphism.
In this paper we test for genetic associations with risk attitude
measures derived from both the psychology and economics literature.
In our sample we find that risk attitude measures from these different
literatures are not strongly correlated. Given the range of genes
implicated in past genetics studies, we search for associations across
polymorphisms in a spectrum of candidate genes that affect
neurotransmitter systems influencing dopamine regulation or in genes
thought to be associated with risk attitudes or impulsive disorders.
We find two single nucleotide polymorphisms (SNPs) in the
gene encoding the alpha 4 nicotine receptor (CHRNA4, rs4603829
and rs4522666) are associated with harm avoidance in our sample
of college normals. Both associations are significant after the false
discovery rate adjustment is implemented to account for multiple
testing. The rs4603829 SNP, which is located in the 39 region, has
not been associated previously with a phenotype. Given the
exploratory nature of our study and the limited size of our sample
(n=67) we also catalogue 22 associations that are significant in the
absence of statistical adjustment for multiple testing. These 22
associations include involve risk attitude measures derived from
both the economics and psychology literature and SNPs affecting
several genes. In particular novelty seeking is associated with
several COMT SNPs while economic risk attitudes are associated
with several VMAT SNPs. These findings suggest an improved
understanding of the genetic basis of risk attitudes must consider
the breadth of methods available for measuring risk attitudes and
look beyond the traditional direct focus on dopamine and
serotonin receptor and transporter genes.
Materials and Methods
Subjects
The study involved 67 subjects (29 female, 8 non-white, mean
age=20.6 years, standard deviation of age=3.2 years) and was
approved by the local Biomedical Internal Review Board. Subjects
were recruited via e-mail from interested university students and
local community members. Exclusion criteria included left-
handedness, color blindness, pregnancy, brain aneurysm, cognitive
impairment, and age less than 18; many criteria were included so
that all subjects might be eligible for subsequent brain imaging
experiments not reported here. Self-reported health histories were
collected; 12 subjects reported ever being diagnosed with
depression, bi-polar disorder or another psychiatric disorder. All
subjects described themselves as either a non-user of tobacco
(n=57) or an occasional user of tobacco (not daily, n=9). All
subjects completed the preferred gambles task while 65 subjects
completed the personality traits inventory. The entire experiment
took approximately 1.5 hours and the average subject payment
was $50; actual payment ranged from $34 to $131 and depended
upon choices made during the preferred gambles task and the roll
of a die.
Risk Attitude Tasks
A Preferred Gambles Task from the Economics
Literature. This task assesses the tendency for individuals to
seek out risky rather than conservative financial opportunities,
which has been show to predict pathological gambling behavior
[33] and to be stable over periods of at least 17 months [34],
suggesting the task is measuring an individual trait rather than a
temporary state regarding financial risk tolerance. In this task,
which is adapted from the economics literature [35], respondents
are presented with a sequence of choices. Each choice is between
two gambles: a safe gamble (e.g., Option A: a 1-in-10 chance of
gaining $15 and a 9-in-10 chance of gaining $12) and a risky
gamble (e.g., Option B: a 1-in-10 chance of gaining $29 and a 9-
in-10 chance of gaining $0.75). Before each decision, respondents
are informed of the difference in the expected values of the two
gambles (for the previous example, the respondent is informed: ‘‘If
both gambles were played 100 times Option A would usually gain
$8.73 more than Option B). After reading the information about
the pair of gambles, respondents must mark one of the two
gambles as preferred on the paper form.
Each respondent is presented with 36 gamble pairs in 4 blocks
of 9. Each choice features one safe gamble and one risky gamble,
though the neutral language ‘Option A’ and ‘Option B’ is used in
place of ‘safe’ and ‘risky’. Within each block the dollar values for
the safe and risky gamble payouts are fixed while probability of
winning the higher dollar value is increased by 0.1 with each
additional choice. For example, continuing the example above, the
second choice in the block would be feature an Option A with a 2-
in-10 chance of gaining $15 and an 8-in-10 chance of gaining $12.
In Block 2 the gamble pairs are similar to the gamble pairs in
Block 1 in terms of the magnitude of rewards at stake and in terms
of the probabilities of receiving high versus low payments.
However, in Block 2 each gamble is now described as a loss
rather than a gain. Specifically, respondents are informed that they
begin each decision in Block 2 with $30 and must choose between
two gambles where all outcomes will result in losing some portion
of that $30 endowment. For example, for the first choice in this
block, Option A is a 1-in-10 chance of losing $15 and a 9-in-10
chance of losing $18, while Option B is a 1-in-10 chance of losing
$1 and a 9-in-10 chance of losing $29.25.
Blocks 3 and 4 mirror Blocks 1 and 2 in all aspects expect the
absolute dollar values, which are increased to $50 and $40 for
Option A and $98 and $2.50 for Option B. The gamble pairs in
Block 3 are described as gains while the gamble pairs in Block 4
are described as losses from a base endowment of $100.
After all subjects chose a preferred gamble from all 9 pairs in
each of the 4 blocks, the experimental moderator collected the
Risk Attitudes and CHRNA4 SNPs
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of the 18 small-magnitude gamble pairs (Blocks 1 and 2) would be
chosen as the basis for payment. That is, only 1 of the 18 gamble
pairs was played for real cash; the subjects were aware of this prior
to choosing and told to treat all choices with equal seriousness.
The experimental moderator rolled another 10-sided die to
determine whether each subject received the high or low cash
payment from their preferred gamble. Finally 1 in 30 subjects was
randomly chosen to receive the large-stakes version of their chosen
gamble in place of the small rewards version. Subjects were briefed
on the nature of this compensation scheme prior to their selection
of preferred gambles.
Two measures result from this task. The first is the % Safe
Gambles among Gains (SGG) measure, which is the percent of
safe gambles chosen from all gamble pairs described as gains
(Blocks 1 and 3). The second is the % Safe Gambles among Large
Stakes (SGL) measure, which is the percent of safe gambles chosen
from all large magnitude gambles (Blocks 3 and 4). Past research in
economics suggests that subjects act more conservatively when
gambles are framed as gains rather than losses [36] and act more
conservatively when the absolute rewards involved in gambles
increase [35].
Personality Traits Novelty Seeking and Harm Avoidance
from the Psychology Literature. Two temperament/
personality phenotypes are measured: novelty seeking (NS) and
harm avoidance (HA), both of which are included in the
Temperament and Character Inventory [18]. NS captures a
subject’s tendency toward exploratory activity and exhilaration in
response to novel stimuli, while HA captures the intensity of a
subject’s response to aversive stimuli and eagerness to avoid such
stimuli. Numeric scores for NS and HA are based on subjects’
ratings of 35 statements for NS and 39 statements for HA where
the statements are drawn from the International Personality
Inventory Pool [37], a public-domain instrument shown to
correlate to major personality inventories including the
Temperament and Character Inventory [38]. The scoring
procedure is described elsewhere [37]. All NS and HA scores
are expressed as a percent of the maximum potential score. Both
NS and HA are designed as trait measures, as instructions direct
individuals to assess the statements in relation to how the subject
generally see himself/herself, though research suggests that HA
may be influenced by the onset of major psychological disorders
such as depression [39].
HA has been associated with neurological response to
hypothetical financial risk games presented in fMRI experiments
[11,40] while NS and HA have been associated with pathological
gambling behavior [4,5,6,41].
Table 1 presents summary statistics for each of the risk attitude
measures in addition to a Spearman Rank correlation matrix. The
p-values for the correlations are adjusted for multiple testing using
the Sidak adjustment. Pearson correlations yield similar qualitative
and quantitative results and are not reported. Tests (both standard
t-tests and the non-parametric Kruskal-Wallis tests) by gender and
race reveal no statistically significant differences across these sub-
groups for any risk attitude measure. Risk attitudes derived from
the same disciplinary field display significant within-field correla-
tion (HS and NA, SGG and SGL), while correlations of risk
attitude measures from different disciplines are uncorrelated and
of similar magnitude as previously documented [28].
Genotypes
Genotyping focused on 98 polymorphisms in genes thought to
affect catecholamine function, or previously implicated in impulse
control issues or associated with risk attitudes. The SNP choice
was calculated with Applied Biosystems SNP Browser 3.0 software
using the haplotype tagging method (r
2=.95). Priority was given to
SNPs located in transcribed RNA (see Table 2). Putative variable
number tandem repeats (VNTR’s) in estrogen receptor 1,
dopamine transporter and monoamine oxidase were also analyzed
([42,43,44], see Table 3). Genomic DNA was isolated from whole
blood using the Flexigene kit (Qiagen). After DNA isolation, DNA
concentration and purity was determined by calculating the A260/
A280 ratio. The subject’s genotype was determined by the
pharmacogenomics core facility at The Ohio State University,
Department of Pharmacology using SNPlex (Applied Biosystems,
Forster City, CA) or fluorescent PCR. Polymorphisms were
checked for Hardy-Weinberg equilibrium (p,0.05) and a
minimum minor allele frequency of 5% using Helix Tree (Golden
Helix, Bozeman, Montana). A total of 81 SNPs (denoted in
Table 2) and all three VNTRs (Table 3) passed these tests and
were used in the association analysis.
Statistical Methods
The genetic association tests used are F-tests of the difference in
the distribution of the risk attitude measure across subjects in
different genotype categories; we implement both a dominant and a
recessive model for each polymorphism and phenotype considered.
Thep-value iscorrectedfor multipletesting usingthefalse discovery
rate (FDR) p-value [45]. FDR is an alternative that controls the
numberoffalse positivesthat isequivalent to the Bonferronimethod
when there are no truly significant results; otherwise it is less
conservative and therefore a more powerful test [46].
Results
Harm Avoidance and CHRNA4
Two CHRNA4 SNPs (rs4603829 and rs4522666) showed a
significant association with HA score (F 1, 62=14.34, p=0.029 and
F 1, 57=11.95, p=0.042, respectively after FDR correction) using a
recessive genetic association model. Both of these SNPs are located in
Table 1. Spearman Rank Correlation Coefficients Among
Tasks.
NS HA SGL SGG
Summary
Statistics
Novelty Seeking 1.000 0.437
(NS) – – – – 0.013
64 (0.179, 0.736)
Harm Avoidance -0.411 1.000 0.426
(HA) 0.004 – – – 0.018
64 64 (0.135, 0.763)
% Safe Gambles – Large
Stakes
-0.063 0.006 1.000 0.387
(SGL) 0.997 1.000 – – 0.020
64 64 66 (0, 0.667)
% Safe Gambles – Gains -0.066 -0.179 0.886 1.000 0.403
(SGG) 0.996 0.642 ,0.001 – 0.019
64 64 66 66 (0.056, 0.778)
Each cell in the first 4 columns of numbers lists the Spearman rank correlation
coefficient, Sidak adjusted p-value and number of observations, respectively.
Each summary statistic cell lists mean, standard error, minimum and maximum
observation, respectively.
doi:10.1371/journal.pone.0006704.t001
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CHRNA4, but could affect alpha4 signaling through other mechanisms,
such as altered mRNA regulation or stability. It is also possible that
these SNPs are not the functional polymorphisms but are linked to a
functional polymorphism elsewhere in the gene.These two SNPs are in
partial linkage disequilibrium (x
2=31.4656, p,0.001, d’=0.751 and
r=0.690). The rs4603829 SNP hasnot been previously associated with
a phenotype while the rs4522666 SNP has been associated with
cigarette smoking among schizophrenics [47].
The minor allele of rs4522666 is associated with a higher HA
score(Table4)andthe minoralleleofrs4603829 isassociated with a
lower HA score (Table 5). Specifically the rs4522666 genotypes AA
and AG are associated with low scores, while the GG genotype is
associated with high scores. The rs4603829 genotypes TT and CT
are associated with low scores while the CC genotype is associated
with high scores. A few individuals had genotypes that gave
conflicting predictions oftheir HA score;specificallyindividuals that
are CT at the rs4603829 locus while being GG at rs4522666 locus.
Iftheseindividualsareremoved from the analysis,theFDRp-values
become more robust (two individuals with incomplete data were
also eliminated, for a total of 7 persons removed from the analysis).
The elimination of these 7 individuals lowered the FDR adjusted p-
value for rs4522666 (F 1, 52=17.75, p=0.0147) and for rs4603829
(F 1, 55=17.27, p=0.00885). These two SNPs were not significantly
associated with any other phenotypes.
Associations with Other Polymorphisms
Our study was small for a genetic association study. The power
of our tests to identify large standardized effects (Cohen’s d=0.80)
with a=0.05 and a Bonferroni adjustment for 84 polymorphisms
(0.05/84=0.000595) is 0.43 given our sample size. Realizing this
limitation, however, we report on several polymorphisms that
showed significant unadjusted associations with one or more of the
phenotypes we measured. These associations are listed in Table 6
and include SNPs in COMT, DAT, DISC1, DRD2, DRD3, ESRa,
NET and TPH and a VNTR in MAOA.
The association between a DAT SNP (rs27072) and novelty
seeking features an uncorrected p-value=0.001 and a FDR
corrected p-value=0.137. NS was associated with 4 different
COMT SNPs, including rs4646312, rs165722, rs4818 and rs4633.
With regard to the economic risk attitude measures, two VMAT2
SNPs (rs363333 and rs1860404) were associated with both SGL
and SGG. ESRa rs3798577 was the only SNP associated with risk
attitudes from both economic and psychology literature.
Discussion
The results reveal a significant association between a psycho-
logical risk attitude measurement and two SNPs in CHRNA4. Each
Table 2. List of SNPs Analyzed.
Gene SNP
CHRNA4 Cholinergic receptor, nicotinic, alpha 4 rs755203, rs1044393, rs1044397*, rs2093107, rs2236196, rs2273502, rs4522666, rs4603829
COMT Catechol-O-methyl transferase rs4633, rs4680*, rs4818, rs165656, rs165722, rs174699, rs4646312, rs740603*
DAO D-amino acid oxidase rs2070588, rs3741775, rs3825251, rs3918347, rs7980427
DAT Dopamine transporter rs6347*, rs6350*, rs27072, rs37022, rs40184, rs1042098, rs2937639, rs464049
DISC1 Disrupted-in-Schizophrenia 1 rs823163, rs913730, rs1000731, rs3738401
DRD2 Dopamine receptor D2 rs6277, rs6279, rs1079595, rs1124493, rs1125394, rs1800497*, rs1984739, rs2075654,
rs2242446, rs4648318, rs6589377, rs7117915, rs7125415, rs11214608, rs12364283
DRD3 Dopamine receptor D3 rs6280, rs226082, rs963468, rs2134655
ESRa Estrogen receptor alpha rs827421, rs988328, rs1801132, rs2228480, rs3798577
HTR2A Serotonin receptor subtype 2A rs6313, rs2070039, rs2246127
MAOA Monoamine oxidase A rs6323*, rs909525*, rs979605*, rs979606*, rs1801291*, rs3027407*
MAOB Monoamine oxidase B rs17462, rs3027452*, rs7879356*
NET Norepinephrine transporter rs3081, rs5569, rs15534, rs36017, rs40434, rs998424, rs2242446, rs2242447, rs2279805
SERT Serotonin transporter r140701, r1872924, r2020934, r3783594, r3794808
TH Tyrosine hydroxylase rs6356, rs6357, rs2070762, rs4074905
TPH2 Tryptophan hydroxylase 2 rs4290270, rs7305115
VMAT2 Vesicular Monoamine Transporter 2 rs14240, rs36339, rs363333, rs363343, rs929493, rs1860404
*SNPs that fail screening criteria for HE equilibrium and sufficient minor allele frequency.
doi:10.1371/journal.pone.0006704.t002
Table 3. List of Variable Number of Tandem Repeats
Analyzed.
Gene Repeat Groupings
DAT Dopamine transporter 9, 10 or more
ESRa Estrogen receptor alpha 18 or fewer, 19 or more
MAOA Monoamine oxidase A 3, 4
doi:10.1371/journal.pone.0006704.t003
Table 4. Harm Avoidance Scores by CHRNA4 rs4522666 SNP.
Genotype Mean Std. Error Count
C/C: 0.568 0.042 10
C/T: 0.404 0.023 29
T/T: 0.393 0.027 25
doi:10.1371/journal.pone.0006704.t004
Risk Attitudes and CHRNA4 SNPs
PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6704of these associations survives correction for multiple comparison
testing. There are several reasons why the significant association
between HA score and two SNPs in CHRNA4 is of interest.
Neuronal nicotinic cholinergic receptors, including CHRNA4, are
of general interest because they modulate the release of several
neurotransmitters, including dopamine, serotonin, gamma-amino
butyric acid (GABA) and glutamate in the ventral tegmental area
[48]. CHRNA4 is highly expressed in the central nervous system
and is, in particular, important in modulation of mesolimbic
dopamine function [49], which suggests it is an appropriate target
for studies concerning reward processing and risk attitudes [49].
Furthermore, polymorphisms in CHRNA4 have been associated
previously with response inhibition as measured using cognitive
tests such as the Stroop Test, Matching Familiar Figures Test,
Tower of London Test and the Continuous Performance Test [50]
and as measured by success in smoking cessation programs [49].
Harm Avoidance is also associated with inhibitory response;
respondents scoring low on HA have been characterized as having
underdeveloped inhibitory responses [51]. Inability to inhibit
response is a classic issue with impulse control disorders such as
pathological gambling (PG) and previous work has revealed
significant associations between HA and PG [4,5,6]. These results
may also hold relevance for understanding the incidence of
impulse control disorders in Parkinson’s patients treated with
dopamine agonists [10] in light of the role that CHRNA4 plays in
dopamine regulation and in light of the data suggesting pre-
morbid risk taking behavior is associated with the risk in
developing impulse control disorders with treatment of Parkinson’s
[52], as well as the prevalence of tobacco use among PD
populations. Research by Takeuchi et al. [53] suggests that
Table 5. Harm Avoidance Scores by CHRNA4 rs4603829 SNP.
Genotype Mean Std. Error Count
G/G: 0.561 0.037 10
A/G: 0.431 0.024 30
A/A: 0.373 0.027 21
Unknown: 0.291 0.087 3
doi:10.1371/journal.pone.0006704.t005
Table 6. SNP Associations with Uncorrected P-values # 0.05.
Marker P-Value F-Stat d.f. FDR* Minor Allele Frequency
Novelty Seeking - Recessive
COMT rs4646312 0.013 6.484 62 1.000 0.484
COMT rs165722 0.016 6.180 60 0.660 0.371
COMT rs4818 0.025 5.244 63 0.711 0.492
NET 2 rs2242446 0.026 5.214 57 0.549 0.246
DISC1 rs3738401 0.030 4.915 63 0.508 0.300
DRD3 rs963468 0.043 4.265 63 0.602 0.292
MAOA VNTR 0.044 4.256 59 0.522 0.361
COMT rs4633 0.049 4.035 63 0.516 0.346
Novelty Seeking – Dominant
DAT rs27072 0.001 11.033 63 0.137 0.154
ESRa rs3798577 0.021 5.574 63 0.981 0.500
Harm Avoidance - Recessive
DRD2 rs11214608 0.018 5.894 62 0.507 0.430
NET rs40434 0.038 4.488 63 0.800 0.385
ESRa rs2228480 0.044 4.206 63 0.622 0.223
% Safe Gambles Large – Dominant
VMAT2 2 rs363333 0.014 6.316 64 1.000 0.189
VMAT2 5 rs1860404 0.017 5.953 64 0.804 0.212
NET 2 rs2242446 0.026 5.243 59 0.786 0.238
DRD3 rs226082 0.033 4.755 65 0.755 0.299
NET 3081 0.048 4.086 63 0.728 0.238
% Safe Gambles Gains – Recessive
ESRa rs3798577 0.036 4.598 65 1.000 0.493
TPH2 2 rs4290270 0.041 4.359 64 1.000 0.386
ESRa rs2228480 0.048 4.050 65 1.000 0.224
% Safe Gambles Gains – Dominant
VMAT2 2 rs363333 0.006 8.165 64 0.529 0.189
VMAT2 5 rs1860404 0.036 4.578 64 1.000 0.212
*p-value adjusted for False Discover Rate associated with multiple comparisons.
doi:10.1371/journal.pone.0006704.t006
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degeneration in Parkinson’s patients.
The SNPs that provided significant association with HA scores
in the present analysis were not the same as the SNPs found to be
significant in either Rigbi et al. [50] or Hutchison et al.[49]. One
of the SNPs from Hutchison et al. (rs2236196) was located in the
39 region of the gene, as were both the SNPs found to be
significantly associated with HA scores in the present work. We
note that the SNPs found significant by Rigbi et al. [50] and
Hutchison et al. [49] are also included in the present set of
analyses but failed to produce significant associations with Harm
Avoidance or any other phenotype. The relevance of these
findings can be resolved only after the underlying molecular
mechanisms are known. We have preliminary evidence, measuring
allelic mRNA expression in human autopsy brain tissues, showing
that the 39 region of CHRNA4 harbors a functional polymorphism
that affects mRNA expression or splicing (W. Sadee, unpublished
results); if confirmed, this would further support a possible role for
marker SNPs in this region.
The association between the DAT SNP rs27072 and NS, which
did not survive significance after correction for multiple compar-
isons (FDR p-value=0.137), also has a linkage to past research.
This SNP has been associated with early onset smoking among
Chinese subjects with severe nicotine dependence [54], alcohol
withdrawal seizures among a sample of alcoholics [55] and
inattention and hyperactivity/impulsivity in a sample of Canadian
children [56]. Furthermore, Voon et al. [52] found NS scores help
predict the onset of impulse control disorders among Parkinsons
patients treated with dopamine agonists. NS was originally viewed
as a trait influenced by variation in the dopamine system, with
studies associating NS with SNPs affecting dopamine receptors,
most notably DRD4 [20], and others have found associations
between NS and DAT SNPs [57], but others have also found
associations between NS and DAT neural density [58].
The significant association between economic risk attitudes and
VMAT2 SNPs is novel in the literature, though we must caution
that the statistical significance of this finding does not survive
adjustment for multiple comparisons. The rs363333 SNP has been
previously implicated in alcohol dependence [59] though our
search of the literature revealed no previous behavioral associa-
tions for the rs1860404 SNP. Previous research involving VMAT2
and inherent genetic variation has indicated the gene as a region of
interest with respect to risk attitudes. For example, cocaine users
lose VMAT2 protein compared to non-cocaine users [60]. This is
of interest as substance addicted individuals have poorer ability to
control impulses toward high risk choices in the Iowa Gambling
Task [61,62]. Other work also links genetic variation in VMAT2 to
impulse control issues. For example, Lin et al. [63] find haplotypes
within VMAT2 to be associated with a protective factor against
alcoholism while Glatt et al. [64] find haplotypes within VMAT2 to
be protective against PD for women.
Several SNPs in COMT were associated with NS, including the
rs4818 SNP that Roussos et al. [30] found to be significantly
associated with behavior in the Iowa Gambling Task. Other
genetic variations in COMT, most notably the Val/Met 158
polymorphism, has been associated with sensation seeking among
women [65], novelty seeking and reward dependence in Chinese
women [66] and extroversion and novelty seeking [25]. Previous
research has associated novelty seeking personality traits with PG
outcomes [4,6].
Given the small sample size involved in this study, independent
replication of these results with larger sample sizes is necessary to
further refine the genetic basis for risk attitude measures. Our
exploratory results suggest that employing several risk attitude
measures drawn from distinct disciplinary literatures can be
important to refining the understanding of any genetic basis as the
degree of correlation found between economic and psychological
measures of risk attitude in this and other samples tends to be low.
Furthermore, while most research on the genetic basis of risk
attitudes have focused directly on dopamine receptors and the
dopamine and serotonin transporter genes, we find that genetic
variation in a broad array of genes with ties to the regulation of
dopamine and serotonin might be important for understanding
individual risk attitudes. For future directions for genetic studies,
the present results set the stage for estimating the cohort size
needed to address and replicate the associations identified here.
Moreover, consideration of the interaction between the various
risk genes, each individually with some potential impact on risk
behavior, has the potential to reveal more accurately the impact of
genetic factors on risk taking behavior.
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